💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Applied Materials denied US CHIPS grant for $4 bln R&D project- Bloomberg

Published 2024-07-31, 09:26 p/m
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
AMAT
-

Investing.com-- Applied Materials Inc (NASDAQ:AMAT) was rejected for funding under the Chips act for a research and development center in Silicon Valley, Bloomberg reported on Thursday. 

Commerce Department officials rejected the chipmaking equipment maker’s bid to gain U.S. funding for a $4 billion facility in Sunnyvale, California, the Bloomberg report said, citing people familiar with the matter. 

Applied Materials had unveiled plans to build the facility a year ago, and had said it wanted subsidies from the government through the Chips and Science Act. The facility was slated to be completed in 2026.

But reports in April had suggested that the firm was already facing difficulties gaining government approval for the required funds, especially after the Biden administration said it was facing “overwhelming demand” for funding rewards.

Applied Materials could not be immediately reached for a comment.

The CHIPS and Science Act was signed into law in August 2022, and was authorized about $280 billion in new funding for boosting domestic chipmaking research and development.

The act included $39 billion in subsidies for chip manufacturing on U.S. soil- with chipmakers including TSMC (NYSE:TSM), Samsung Electronics Co Ltd (KS:005930) and SK Hynix Inc (KS:000660) winning grants to build U.S. chipmaking factories. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.